View Older Stories View More Recent Stories
-
Odyssey Marine Exploration Reports Record Fourth Quarter and Full Year 2013 Results
-
Can-Fite BioPharma (CANF) Closes 1.48M ADS, Warrants Private Placement
-
Roth Starts JA Solar (JASO) at Buy; Undervalued Name has Robust Balance Sheet, Strong Pipeline
-
Electrovaya to Present at the Roth Capital Conference on March 12, 2014
-
BioLineRx (BLRX) Closes 9.66M ADS Offering for Gross Proceeds of $24.1M
-
Peregrine (PPHM) Risk/Reward Still Favorable; Plenty to Look Forward to in FY14 - Roth
-
Notable Analyst Rating Changes 03/07: (GTAT) (CCRN) (PRU) Upgraded; (ALU) (NMRX) (VMEM) Downgraded
-
Roth Capital Starts JA Solar Holdings Co., Ltd. (JASO) at Buy
-
Roth Capital Starts Applied Micro Circuits (AMCC) at Buy
-
OXiGENE Announces Presentation at the ROTH Conference on March 11, 2014
-
Roth Keeps Spectrum Pharma (SPPI) at Buy; Q4 Results are Speed Bump on Road to Profitability
-
AETI CEO to Present at ROTH Capital Partners 26th Annual Growth Stock Conference
-
Roth Capital Starts Conatus Pharmaceuticals (CNAT) at Buy
-
Roth Capital Downgrades Kindred Biosciences (KIN) to Neutral
-
Applied Optoelectronics (AAOI) Announces 1.3M Common Follow-On Offering
-
Applied Optoelectronics Files Registration Statement for Proposed Follow-on Public Offering
-
Roth Keeps Verastem (VSTM) at Buy; Sees Positioned for 'Potentially Transformative Year'
-
Pixelworks (PXLW) PT Raised to $10 at Roth
-
Notable Analyst Rating Changes 03/06: (BIIB) (COG) (HA) Upgraded; (AUXL) (LOV) (ARTC) Downgraded
-
Buy Canadian Solar (CSIQ) on Weakness; FY14 Outlook Reinforces Strength - Roth
-
GSV Capital Corp. to Present at the 26th Annual ROTH Conference on March 10, 2014
-
Roth Capital Starts Durata Therapeutics (DRTX) at Buy
-
Vical to Present at the ROTH Capital Partners 26th Annual Growth Stock Conference
-
Notable Analyst Rating Changes 03/05: (P) (TRMB) (DST) Upgraded; (DDS) (SPLS) (PEI) Downgraded
-
Pre-Open Stock Movers 3/5: (FCEL) (ARWR) (SWHC) Higher; (XOMA) (HCI) (CSIQ) Lower (more...)
-
ANI Pharma (ANIP) Prices 1.4M Common Stock Offering at $31/Share
-
Arno Therapeutics to Present at 26th Annual ROTH Conference
-
Roth Restarts Cytokinetics (CYTK) at Buy; Get in Now Ahead of April '14 ALS Data
-
Roth Capital Re-Initiated Cytokinetics (CYTK) at Buy
-
After Hours Stock Movers 3/4: (BV) (SWHC) (AVAV) Higher; (XOMA) (CHEF) (THOR) Lower (more...)
-
ANI Pharma (ANIP) Plans Common Stock Offering
-
Reis, Inc. to Present to Investors at Roth Capital Partners 26th Annual Conference
-
JinkoSolar (JKS) Issues Confident Q4 Beat, FY14 Outlook is Strong; Roth Keeps at 'Buy'
-
Near-Term Volatility Expected on Exec Shift, But Fundamentals Inact for Synta Pharma (SNTA) - Roth
-
BioLineRx (BLRX) Prices 8.4M Offering at $2.50/ADS
-
OvaScience (OVAS) Prices 5M Offering at $10/Share
-
Investors Probably Already Looking Past SolarCity (SCTY) Accounting Snafu - Roth
-
Roth Capital Starts Constant Contact (CTCT) at Buy
-
Quadrant 4 Systems to Present at Roth Capital Partners 26th Annual Conference
-
BioLineRx (BLRX) Lower on Stock Offering
-
RGS Energy to Present at the 26th Annual ROTH Conference on March 10, 2014
-
Dendreon (DNDN) Makes Progress in FY13, But Road Ahead Still Bumpy - Roth
-
Roth Still Positive on Ligand (LGND) Following Promacta sNDA Submission
-
Pedevco (PED) to Offer Common Stock
-
Neptune Technologies (NEPT) Prices 10M Shares at $2.50
-
Broadwind Energy to Present at the 26th Annual Roth Conference
-
Neptune Tech (NEPT) Commences Common Stock Offering
-
Landec to Present at the 26th Annual ROTH Conference on March 12, 2014
-
I.D. Systems to Present at 26th Annual ROTH Conference on March 11, 2014
-
Black Diamond to Present at the 26th Annual ROTH Conference on March 11, 2014

